Led Medical (LEDIF) 0.1716 $LEDIF
LED Medical Diagnostics' VELscope(R) Vx Receives Regulatory Approval for Distribution in China
Marketwired - Wed Sep 09, 6:30AM CDT
LED Medical Diagnostics Inc. ("LED Medical" or "the Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) and its subsidiary LED Dental have received regulatory approval for the distribution of the VELscope® Vx Enhanced Oral Assessment System in China, opening up a large new market for the award-winning adjunctive screening device. Geneformation Technology, a distributor of laboratory equipment and consumables with offices in China, Hong Kong and the United States, has worked closely with the Company to obtain regulatory approval for the VELscope Vx from the China Food and Drug Administration. As of August 6, 2015, the VELscope Vx Enhanced Oral Assessment System is approved for sale in China as a medical apparatus, Category I, under approval number "�械�20151176."
LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Inc. Reports 2015 Second Quarter Results
Marketwired - Mon Aug 31, 8:51PM CDT
LED Medical Diagnostics Inc. ("LED Medical" or the "Company" (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) today announced its financial results for the second quarter ended June 30, 2015, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". LED Medical achieved strong annual and sequential growth with revenue of US$3.3 million in the second quarter 2015, an increase of 106% over the second quarter of 2014 and an increase of 34% over the prior quarter ended March 31, 2015. The Company's results are presented in comparison to the first quarter ended June 30, 2014. All balances are expressed in United States dollars unless otherwise stated.
LMD.VN: 0.220 (-0.020)
LED Medical Provides August 2015 Business Update
Marketwired - Fri Aug 07, 9:50PM CDT
LED Medical Diagnostics Inc. ("LED Medical" or "the Company" (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) and its subsidiary, LED Dental, has provided a business update that outlines ongoing developments in the organization that will be shaping its activities over the next several months. Included in the update is a summary of the latest additions to the LED Dental imaging product portfolio, international market expansion for the Rayscan Alpha - Expert 3D Imaging System, and an update on the VELscope product line.
LMD.VN: 0.220 (-0.020)
LED Medical Announces Distribution Agreement With EnvisionTec Inc.
Marketwired - Tue Aug 04, 7:02AM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company" announced today that it has entered into a distribution agreement with 3D printer manufacturer EnvisionTec Inc., becoming a provider of EnvisionTec's 3D printing solutions to dentists, dental specialists and dental laboratories across the United States and Canada.
LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Announces Completion of Issuance of Senior Secured Debentures Totaling CDN$1.1 Million
Marketwired - Wed Jul 22, 1:44PM CDT
LED Medical Diagnostics Inc. ("LED" or the "Company" (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) announced today that it has completed a financing of CDN$1,100,000 through the issuance of 10% senior secured debentures of the Company each in the amount of CDN$10,000 (the "Debentures" and maturing after 12 months. The Debentures were issued as part of a non-brokered private placement of units (each a "Unit" with each Unit consisting of: (i) a Debenture; and (ii) 5,950 common share purchase warrants of the Company (each a "Warrant". The subscription price for each Unit was CDN$10,000.
LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Announces Proposed Issuance of Senior Secured Debentures
Marketwired - Wed Jul 15, 6:30PM CDT
LED Medical Diagnostics Inc. ("LED" or the "Company" (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) announces that it is proposing a financing of Cdn$1,100,000 through the issuance of 10% senior secured debentures of the Company each in the amount of CDN$10,000 (the "Debentures" and maturing 12 months from the closing date of the financing (the "Closing Date". The Debentures will be issued to lenders including the Bloom Burton Healthcare Lending Trust as part of a non-brokered private placement of units (each a "Unit" with each Unit consisting of: (i) a Debenture; and (ii) 5,950 common share purchase warrants of the Corporation (each a "Warrant". The subscription price for each Unit will be CDN$10,000.
LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics' VELscope(R) Vx Receives 2015 Pride Institute's "Best of Class" Technology Award
Marketwired - Mon Jul 13, 7:00PM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company", has proudly announced that its VELscope® Vx Enhanced Oral Assessment System has received the Pride Institute's "Best of Class" Technology Award, making 2015 the fifth consecutive year that the VELscope has received this distinction as the market-leading device for adjunctive oral screening. The VELscope is one of only two products to have a five-year run as "Best of Class," putting the device among very elite company.
LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Announces Preliminary Q2 2015 Financial Results
Marketwired - Wed Jul 08, 9:00PM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company" is pleased to announce today that preliminary revenue numbers for the quarter ending June 30, 2015 are expected to be in the range of $3.0-$3.3 million, as measured in US$, representing an approximate 100% increase over the prior year period of $1.6 million. The Company had expected that its year to date revenue for the six month period ended June 30, 2015 to be in the range of $5.4 million to $5.6 million, representing a significant increase of 115% over the prior year period of $2.6 million. These revenue results are preliminary only and subject to finalization by the Company.
LMD.VN: 0.220 (-0.020)
LED Medical: Bringing A SaaS SMB/Enterprise Solution To The Dental Practice
Dallas Salazar - at Seeking Alpha - Tue Jun 16, 6:04PM CDT
LED Dental Announces 3Shape Distribution Agreement
Marketwired - Mon Jun 15, 7:01AM CDT
LED Medical Diagnostics Inc. ("LED Medical" or "the Company" (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) has announced an agreement that makes LED Medical subsidiary LED Dental the newest provider of 3Shape's 3D intraoral digital impression and desktop scanners.
LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics, Inc. (LMD) to Present at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on June 10
GlobeNewswire - Thu Jun 04, 7:02AM CDT
LED Medical Diagnostics, Inc. (TSX-V:LMD), dental imaging services operator and technology company, will be presenting at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on Wednesday, June 10. The event is a gathering of the brightest emerging growth small-cap and pre-IPO companies to present and network with an exclusive group of top-level institutional investors.
LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics' VELscope(R) Vx Receives Regulatory Approval for Distribution in China
Marketwired - Wed Sep 09, 6:30AM CDT
LED Medical Diagnostics Inc. ("LED Medical" or "the Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) and its subsidiary LED Dental have received regulatory approval for the distribution of the VELscope® Vx Enhanced Oral Assessment System in China, opening up a large new market for the award-winning adjunctive screening device. Geneformation Technology, a distributor of laboratory equipment and consumables with offices in China, Hong Kong and the United States, has worked closely with the Company to obtain regulatory approval for the VELscope Vx from the China Food and Drug Administration. As of August 6, 2015, the VELscope Vx Enhanced Oral Assessment System is approved for sale in China as a medical apparatus, Category I, under approval number "�械�20151176." LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Inc. Reports 2015 Second Quarter Results
Marketwired - Mon Aug 31, 8:51PM CDT
LED Medical Diagnostics Inc. ("LED Medical" or the "Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) today announced its financial results for the second quarter ended June 30, 2015, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". LED Medical achieved strong annual and sequential growth with revenue of US$3.3 million in the second quarter 2015, an increase of 106% over the second quarter of 2014 and an increase of 34% over the prior quarter ended March 31, 2015. The Company's results are presented in comparison to the first quarter ended June 30, 2014. All balances are expressed in United States dollars unless otherwise stated. LMD.VN: 0.220 (-0.020)
LED Medical Provides August 2015 Business Update
Marketwired - Fri Aug 07, 9:50PM CDT
LED Medical Diagnostics Inc. ("LED Medical" or "the Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) and its subsidiary, LED Dental, has provided a business update that outlines ongoing developments in the organization that will be shaping its activities over the next several months. Included in the update is a summary of the latest additions to the LED Dental imaging product portfolio, international market expansion for the Rayscan Alpha - Expert 3D Imaging System, and an update on the VELscope product line. LMD.VN: 0.220 (-0.020)
LED Medical Announces Distribution Agreement With EnvisionTec Inc.
Marketwired - Tue Aug 04, 7:02AM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company"
announced today that it has entered into a distribution agreement with 3D printer manufacturer EnvisionTec Inc., becoming a provider of EnvisionTec's 3D printing solutions to dentists, dental specialists and dental laboratories across the United States and Canada. LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Announces Completion of Issuance of Senior Secured Debentures Totaling CDN$1.1 Million
Marketwired - Wed Jul 22, 1:44PM CDT
LED Medical Diagnostics Inc. ("LED" or the "Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) announced today that it has completed a financing of CDN$1,100,000 through the issuance of 10% senior secured debentures of the Company each in the amount of CDN$10,000 (the "Debentures" and maturing after 12 months. The Debentures were issued as part of a non-brokered private placement of units (each a "Unit" with each Unit consisting of: (i) a Debenture; and (ii) 5,950 common share purchase warrants of the Company (each a "Warrant". The subscription price for each Unit was CDN$10,000. LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Announces Proposed Issuance of Senior Secured Debentures
Marketwired - Wed Jul 15, 6:30PM CDT
LED Medical Diagnostics Inc. ("LED" or the "Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) announces that it is proposing a financing of Cdn$1,100,000 through the issuance of 10% senior secured debentures of the Company each in the amount of CDN$10,000 (the "Debentures" and maturing 12 months from the closing date of the financing (the "Closing Date". The Debentures will be issued to lenders including the Bloom Burton Healthcare Lending Trust as part of a non-brokered private placement of units (each a "Unit" with each Unit consisting of: (i) a Debenture; and (ii) 5,950 common share purchase warrants of the Corporation (each a "Warrant". The subscription price for each Unit will be CDN$10,000. LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics' VELscope(R) Vx Receives 2015 Pride Institute's "Best of Class" Technology Award
Marketwired - Mon Jul 13, 7:00PM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or "the Company"
, has proudly announced that its VELscope® Vx Enhanced Oral Assessment System has received the Pride Institute's "Best of Class" Technology Award, making 2015 the fifth consecutive year that the VELscope has received this distinction as the market-leading device for adjunctive oral screening. The VELscope is one of only two products to have a five-year run as "Best of Class," putting the device among very elite company. LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics Announces Preliminary Q2 2015 Financial Results
Marketwired - Wed Jul 08, 9:00PM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company"
is pleased to announce today that preliminary revenue numbers for the quarter ending June 30, 2015 are expected to be in the range of $3.0-$3.3 million, as measured in US$, representing an approximate 100% increase over the prior year period of $1.6 million. The Company had expected that its year to date revenue for the six month period ended June 30, 2015 to be in the range of $5.4 million to $5.6 million, representing a significant increase of 115% over the prior year period of $2.6 million. These revenue results are preliminary only and subject to finalization by the Company. LMD.VN: 0.220 (-0.020)
LED Medical: Bringing A SaaS SMB/Enterprise Solution To The Dental Practice
Dallas Salazar - at Seeking Alpha - Tue Jun 16, 6:04PM CDT
LED Dental Announces 3Shape Distribution Agreement
Marketwired - Mon Jun 15, 7:01AM CDT
LED Medical Diagnostics Inc. ("LED Medical" or "the Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) has announced an agreement that makes LED Medical subsidiary LED Dental the newest provider of 3Shape's 3D intraoral digital impression and desktop scanners. LMD.VN: 0.220 (-0.020)
LED Medical Diagnostics, Inc. (LMD) to Present at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on June 10
GlobeNewswire - Thu Jun 04, 7:02AM CDT
LED Medical Diagnostics, Inc. (TSX-V:LMD), dental imaging services operator and technology company, will be presenting at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on Wednesday, June 10. The event is a gathering of the brightest emerging growth small-cap and pre-IPO companies to present and network with an exclusive group of top-level institutional investors.
LMD.VN: 0.220 (-0.020)
